BerGenBio ASA (BRRGF)
USD 2.5
(0.0%)
USD 2.5
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 354 Thousand NOK | -20876.25% |
| 2022 | 39.65 Thousand USD | -54.76% |
| 2021 | 87.66 Thousand USD | 100.84% |
| 2020 | -10.37 Million USD | -61.86% |
| 2019 | -6.41 Million USD | 13.45% |
| 2018 | -7.4 Million USD | -31300.55% |
| 2017 | -23.59 Thousand USD | 1.88% |
| 2016 | -24.04 Thousand USD | -18.92% |
| 2015 | -20.22 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | -1.58 Million USD | -4.2% |
| 2024 Q2 | -9825.90 USD | 99.39% |
| 2023 Q1 | -668.15 USD | -101.68% |
| 2023 Q3 | -10.18 Thousand USD | -1463.05% |
| 2023 Q4 | -1.61 Million USD | -15751.47% |
| 2023 Q2 | -651.42 USD | 2.5% |
| 2023 FY | -8.23 Million USD | -20876.25% |
| 2022 Q2 | -31.67 Thousand USD | 11.98% |
| 2022 FY | 39.65 Thousand USD | -54.76% |
| 2022 Q4 | 39.65 Thousand USD | 408.45% |
| 2022 Q3 | -12.85 Thousand USD | 59.41% |
| 2022 Q1 | -35.98 Thousand USD | -141.05% |
| 2021 Q2 | -38.92 Thousand USD | 0.8% |
| 2021 FY | 87.66 Thousand USD | 100.84% |
| 2021 Q1 | -39.24 Thousand USD | 0.0% |
| 2021 Q4 | 87.66 Thousand USD | 329.1% |
| 2021 Q3 | -38.26 Thousand USD | 1.71% |
| 2020 FY | -10.37 Million USD | -61.86% |
| 2019 FY | -6.41 Million USD | 13.45% |
| 2018 FY | -7.4 Million USD | -31300.55% |
| 2017 FY | -23.59 Thousand USD | 1.88% |
| 2016 FY | -24.04 Thousand USD | -18.92% |
| 2015 FY | -20.22 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 14.99 Million USD | 97.64% |
| Nanobac Pharmaceuticals, Incorporated | 3102.00 USD | -11311.992% |
| SQZ Biotechnologies Company | 9.79 Million USD | 96.386% |
| Evofem Biosciences, Inc. | 11.7 Million USD | 96.976% |
| Santhera Pharmaceuticals Holding AG | 119.1 Million USD | 99.703% |
| Mesoblast Limited | -35.16 Million USD | 101.007% |
| Propanc Biopharma, Inc. | -34.15 Thousand USD | 1136.603% |
| Genus plc | 178.7 Million USD | 99.802% |
| VioQuest Pharmaceuticals, Inc. | - USD | -Infinity% |
| CNBX Pharmaceuticals Inc. | 410.16 Thousand USD | 13.693% |
| Marizyme, Inc. | 457.7 Thousand USD | 22.657% |
| ContraFect Corporation | -154 Thousand USD | 329.87% |
| Nymox Pharmaceutical Corporation | -11 Thousand USD | 3318.182% |
| PsyBio Therapeutics Corp. | -50 Thousand USD | 808.0% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 76.76 Thousand USD | -361.172% |
| Intellipharmaceutics International Inc. | 65.72 Thousand USD | -438.583% |
| AXIM Biotechnologies, Inc. | -387.5 Thousand USD | 191.355% |
| MultiCell Technologies, Inc. | 49.32 USD | -717661.557% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 40.26 Million USD | 99.121% |
| EV Biologics, Inc. | 48.9 Thousand USD | -623.926% |
| Q BioMed Inc. | -8988.00 USD | 4038.585% |
| Emmaus Life Sciences, Inc. | 28.25 Million USD | 98.747% |
| Neon Bloom, Inc. | - USD | -Infinity% |
| Mosaic ImmunoEngineering Inc. | - USD | -Infinity% |
| Biomind Labs Inc. | -15.42 Thousand USD | 2395.124% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 220.1 Million USD | 99.839% |
| Oncotelic Therapeutics, Inc. | 70 Thousand USD | -405.714% |
| Skye Bioscience, Inc. | -124.25 Thousand USD | 384.907% |
| Therapeutic Solutions International, Inc. | 62.22 Thousand USD | -468.894% |
| THC Farmaceuticals, Inc. | -4952.00 USD | 7248.627% |
| Arch Therapeutics, Inc. | -2439.00 USD | 14614.145% |
| IMV Inc. | -962.29 Thousand USD | 136.787% |
| Acro Biomedical Co., Ltd. | 140.5 Thousand USD | -151.957% |
| Curative Biotechnology, Inc. | -97.51 Thousand USD | 463.021% |
| GB Sciences, Inc. | -624.00 USD | 56830.769% |
| Alpha Cognition Inc. | -86.02 Thousand USD | 511.494% |
| HST Global, Inc. | - USD | -Infinity% |
| CSL Limited | 7.56 Billion USD | 99.995% |
| Halberd Corporation | -208.00 USD | 170292.308% |
| Enzolytics Inc. | 30.7 Thousand USD | -1052.794% |
| Resverlogix Corp. | - USD | -Infinity% |
| Affymax, Inc. | 1.35 Million USD | 73.916% |
| SYBLEU INC | 11.69 Thousand USD | -2926.676% |
| Nuo Therapeutics, Inc. | 482.43 Thousand USD | 26.622% |
| argenx SE | 1.1 Billion USD | 99.968% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | -25.79 Million USD | 101.372% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | - USD | -Infinity% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | 617.38 Thousand USD | 42.661% |
| Zenith Capital Corp. | - USD | -Infinity% |
| Genscript Biotech Corporation | 409.55 Million USD | 99.914% |
| Ember Therapeutics, Inc. | - USD | -Infinity% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | -8856.00 USD | 4097.29% |
| WPD Pharmaceuticals Inc. | - USD | -Infinity% |
| American Oriental Bioengineering, Inc. | 44.35 Million USD | 99.202% |
| Provectus Biopharmaceuticals, Inc. | -1.14 Million USD | 131.01% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | 987.98 Thousand USD | 64.169% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 9.61 Million USD | 96.317% |
| Cotinga Pharmaceuticals Inc. | -83.84 Thousand USD | 522.188% |
| BioStem Technologies, Inc. | 15.42 Million USD | 97.705% |
| ONE Bio Corp. | 20.12 Million USD | 98.241% |
| Reve Technologies, Inc. | - USD | -Infinity% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | - USD | -Infinity% |
| Agentix Corp. | - USD | -Infinity% |
| LadRx Corporation | -11.83 Thousand USD | 3091.128% |
| Cell Source, Inc. | - USD | -Infinity% |
| ProtoKinetix, Incorporated | -48.25 Thousand USD | 833.542% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | -100.498% |
| Regen BioPharma, Inc. | 176.56 Thousand USD | -100.498% |
| NovAccess Global Inc. | - USD | -Infinity% |
| Endonovo Therapeutics, Inc. | -514.51 Thousand USD | 168.803% |
| Itoco Inc. | - USD | -Infinity% |
| Rasna Therapeutics, Inc. | - USD | -Infinity% |
| Pathfinder Cell Therapy, Inc. | - USD | -Infinity% |
| Kadimastem Ltd | -630.13 Thousand USD | 156.178% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | - USD | -Infinity% |
| CytoDyn Inc. | -29 Thousand USD | 1320.69% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | - USD | -Infinity% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Qrons Inc. | - USD | -Infinity% |
| Alseres Pharmaceuticals, Inc. | 450.04 Thousand USD | 21.341% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | -319.5 Thousand USD | 210.796% |
| Rebus Holdings, Inc. | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | - USD | -Infinity% |
| International Stem Cell Corporation | 4.6 Million USD | 92.318% |
| Bioxytran, Inc. | -8285.00 USD | 4372.782% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | - USD | -Infinity% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | - USD | -Infinity% |
| Adhera Therapeutics, Inc. | - USD | -Infinity% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | - USD | -Infinity% |
| Innovation Pharmaceuticals Inc. | -373 Thousand USD | 194.906% |
| Neutra Corp. | 14.33 Thousand USD | -2369.48% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 531.707% |
| PureTech Health plc | -1.6 Million USD | 122.084% |
| Coeptis Therapeutics, Inc. | -1 Million USD | 135.356% |
| IXICO plc | 3.27 Million USD | 89.174% |
| IntelGenx Technologies Corp. | -694 Thousand USD | 151.009% |
| Gelesis Holdings, Inc. | -1.79 Million USD | 119.765% |
| CSL Limited | 7.7 Billion USD | 99.995% |
| Cellectis S.A. | 18 Thousand USD | -1866.667% |